BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2192092)

  • 1. The role of data audits in detecting scientific misconduct.
    JAMA; 1990 Jul; 264(1):35-8. PubMed ID: 2192092
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of data audits in detecting scientific misconduct. Results of the FDA program.
    Shapiro MF; Charrow RP
    JAMA; 1989 May; 261(17):2505-11. PubMed ID: 2704109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data audit by a regulatory agency: its effect and implication for others.
    Shapiro MF
    Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
    [No Abstract]   [Full Text] [Related]  

  • 4. Scientific misconduct: undue process.
    Efron R
    Account Res; 1993; 3(2-3):223-38. PubMed ID: 11652297
    [No Abstract]   [Full Text] [Related]  

  • 5. A call for the development of "Good Research Practices" (GRP) guidelines.
    Glick JL; Shamoo AE
    Account Res; 1993; 2(4):231-5. PubMed ID: 11652143
    [No Abstract]   [Full Text] [Related]  

  • 6. Editors and auditors.
    Rennie D
    JAMA; 1989 May; 261(17):2543-5. PubMed ID: 2704114
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of federal regulations in assuring research integrity.
    Friedman PJ
    Account Res; 1993; 3(2-3):111-6. PubMed ID: 11652290
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US Government inquiry bodies dismiss scientific misconduct charges against AIDS researchers.
    Marwick C
    JAMA; 1993 Dec; 270(22):2665-6. PubMed ID: 8133572
    [No Abstract]   [Full Text] [Related]  

  • 10. Federal health officials continue to reorganize offices for investigating scientific misconduct.
    Marwick C
    JAMA; 1992 Aug; 268(7):848. PubMed ID: 1640594
    [No Abstract]   [Full Text] [Related]  

  • 11. Definitions and boundaries of research misconduct: perspectives from a federal government viewpoint.
    Price AR
    J Higher Educ; 1994; 65(3):286-97. PubMed ID: 11653365
    [No Abstract]   [Full Text] [Related]  

  • 12. From Baltimore to Bell Labs: reflections on two decades of debate about scientific misconduct.
    Resnik DB
    Account Res; 2003; 10(2):123-35. PubMed ID: 14577424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ensuring scientific integrity in research: aspects of fairness and justice.
    Green HP
    Account Res; 1993; 3(2-3):209-13. PubMed ID: 11652295
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioethics and applied biomaterials.
    Saha S; Saha P
    J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924
    [No Abstract]   [Full Text] [Related]  

  • 15. Pitching doctors.
    Wilkes MS; Shuchman M
    N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
    [No Abstract]   [Full Text] [Related]  

  • 16. Misconduct in science.
    Budetti PP
    Fam Med; 1990; 22(2):99. PubMed ID: 2323502
    [No Abstract]   [Full Text] [Related]  

  • 17. The letter or the spirit. Consent for research in CPR.
    Olson CM
    JAMA; 1994 May; 271(18):1445-7. PubMed ID: 8176805
    [No Abstract]   [Full Text] [Related]  

  • 18. Rights to due process in instances of possible scientific misconduct.
    Hallum JV; Hadley SW
    Endocrinology; 1991 Feb; 128(2):643-4. PubMed ID: 1989853
    [No Abstract]   [Full Text] [Related]  

  • 19. The federal research misconduct regulations as viewed from the research universities.
    Wright DE
    Centen Rev; 1994; 38(2):249-72. PubMed ID: 11656759
    [No Abstract]   [Full Text] [Related]  

  • 20. Scientific misconduct. Back to the drawing board.
    Anderson C
    Nature; 1991 Mar; 350(6314):100. PubMed ID: 1848681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.